Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,304 papers from all fields of science
Search
Sign In
Create Free Account
Synechococcus-like str. P211
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
LibGuides: HPER P211: Introduction to Sport Management: Social Entrepreneurship
Kathleen A. Hanna
2016
Corpus ID: 235939296
2016
2016
LibGuides: HPER P211: Introduction to Sport Management: Social Entrepreneurship
R. Hinrichs
2016
Corpus ID: 228409597
2016
2016
LibGuides: HPER P211: Introduction to Sport Management: Find Books
R. Hinrichs
2016
Corpus ID: 230128937
2016
2016
LibGuides: HPER P211 - Introduction to Sport Management: Home
Kathleen A. Hanna
2016
Corpus ID: 233120176
Review
2015
Review
2015
Abstract T P211: Continued Participation in a Telestroke Program Improves Time to Intravenous Thrombolysis
Jamal N Muthana
,
J. Conners
,
+4 authors
V. Lee
2015
Corpus ID: 70747290
Background: Improved clinical outcomes after intravenous tissue plasminogen activator (IV tPA) are time dependent. Participation…
Expand
2013
2013
ISPF AUTHOR INDEX
Abdul Aziz
,
Luiz Fernando Souza
,
+10 authors
Vivian Aparecida
2013
Corpus ID: 50687344
Abdelrahman, Wael, M84 Abidin, Zain, M7 Abou-Saad, Shaymaa, P173 Abraham, Mathew, M3 Abudabos, Alaeldein, M83, P169 Adedokun, S.A…
Expand
2009
2009
P211 EUREXA : étude internationale, comparant le délai de survenue de l’échec au traitement par exénatide ou gliméripide, ajouté à la Metformine. Caractéristiques d’inclusion des patients français
C. Salaun-Martin
,
C. Bonnard
,
+4 authors
B. Guerci
2009
Corpus ID: 74557179
1997
1997
P211 ウサギ頚動脈バルーン傷害モデルにおけるデヒドロエピアンドロステロンサルフェート(DHEA-S)の血管内膜肥厚抑制効果
伊井 正明
,
福井 亮介
,
+9 authors
大澤 仲昭
1997
Corpus ID: 196212656
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE